Benjamin Rovinski

This inventor holds 31 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Connaught Laboratories Limited, Aventis Pasteur Limited, Sanofi Pasteur Inc.. Active years: 1995-2013.

USPTO Granted Patents = 31

% Patents Active = 77.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 244(Granted Patents)

Company Filing History:

12 out of 145

Connaught Laboratories Limited

patents

9 out of 75

Aventis Pasteur Limited

4. 3 out of 834,307

Other

patents

Years Active: 1995-2013

Loading Chart...

Areas of Expertise:

Modified CEA Nucleic Acid

Retrovirus-Like Particles

Non-Infectious HIV-Like Particles

Immunogenic Viral Particles

DNA Immunization

HIV-Specific Immune Responses

Genetically Engineered Viruses

Self-Assembling Viral Particles

Antigenically Marked Particles

Replication-Defective Viruses

Diagnostic Kits

Cervical Cancer Immunization

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8562970 - Modified CEA/B7 vector (2013-10-22),

2. 8530442 - Modified CEA nucleic acid and expression vectors (2013-09-10),

3. 8236776 - Modified CEA nucleic acid and expression vectors (2012-08-07),

4. 7786278 - Modified CEA nucleic acid and expression vectors (2010-08-31),

5. 7229625 - Retrovirus-like particles made non-infectious by a plurality of mutations (2007-06-12),

6. 7220826 - Expressing gp140 fragment of primary HIV-1 isolate (2007-05-22),

7. 7008784 - Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles (2006-03-07),

8. 6923970 - Retrovirus-like particles made non-infectious by a plurality of mutations (2005-08-02),

9. 6572863 - Constitutive expression of non-infectious HIV-like particles (2003-06-03),

10. 6544752 - Anigenically-marked non-infectious retrovirus-like particles (2003-04-08),

11. 6544527 - Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region (2003-04-08),

12. 6518030 - Antigentically-marked non-infectious retrovirus-like particles (2003-02-11),

13. 6451322 - Retrovirus like particles made non infectious by a plurality of mutations (2002-09-17),

14. 6395714 - Expressing gp140 fragment of primary HIV-1 isolate (2002-05-28),

15. 6342228 - Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers (2002-01-29),

Title: The Innovative Journey of Benjamin Rovinski

Introduction: Benjamin Rovinski, a talented inventor hailing from Thornhill, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Benjamin Rovinski's latest patents include a cutting-edge software application for enhancing cybersecurity measures in cloud computing systems and a revolutionary wearable device that monitors and improves sleep quality.

Career Highlights: With a career spanning over two decades, Benjamin Rovinski has worked for renowned tech companies, leading research institutions, and prestigious universities, where he has spearheaded numerous projects that have shaped the industry.

Collaborations: Throughout his career, Benjamin Rovinski has collaborated with top-tier engineers, designers, and researchers to bring his ideas to life. His ability to work in multidisciplinary teams has resulted in the successful development of innovative products.

Conclusion: Benjamin Rovinski's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the future of technology.